Condition
CKD
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 26 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
26 shownA Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.NCT07496177 · 2026-07-09
RECRUITINGComparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)NCT07304817 · 2026-05-12
RECRUITINGDigital Care for Holistic Health in Older Adults With Diabetes and MultimorbidityNCT07310849 · 2026-05-12
RECRUITINGPeriodontal Disease in Rare Renal Disorders (PERIO-RA-RE)NCT07575347 · 2026-05-04
RECRUITINGIntegrated Approach in Frail Older People with Atrial FibrillationNCT06775028 · 2024-04-11
RECRUITINGGenetics in the Progression of NephropathiesNCT06416761 · 2006-05-19
RECRUITINGPatient-centred Intervention With Virtual Support for Obesity and Kidney Transplant AccessNCT07858331 · 2027-01-01
NOT_YET_RECRUITINGEffect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney DiseaseNCT07268807 · 2025-12-01
NOT_YET_RECRUITINGTreatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical TrialNCT06094920 · 2024-07-29
COMPLETEDFib to Alb Ratio in Type 2 DkdNCT05691985 · 2024-07-25
COMPLETEDA Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNCT05936151 · 2023-07-20
COMPLETEDThe Living With a Long-Term Condition StudyNCT06072287 · 2023-06-28
UNKNOWNNurse-led Medication Self-management Intervention in the Improvement of Medication AdherenceNCT05645653 · 2022-12-01
UNKNOWNThe ORTIZ Study: Optimising RASi Therapy With SZCNCT04983979 · 2022-06-17
TERMINATEDThe Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic PatientsNCT04365517 · 2021-12-29
UNKNOWNStatStrip A Glucose/Creatinine Meter System Lay User Study EvaluationNCT05144971 · 2021-10-28
COMPLETEDEffect of Subcutaneous Semaglutide on Kidney Transplant CandidacyNCT04741074 · 2021-07-23
TERMINATEDExercise Intervention in Patients With Metabolic Syndrome and Renal Disease: a Prospective StudyNCT06576518 · 2021-06-10
COMPLETEDDecentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.NCT06374043 · 2021-05-11
COMPLETEDFoot Abnormalities in Diabetic CKD PatientsNCT04572945 · 2021-04-01
UNKNOWNHome-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 StudyNCT04520191 · 2021-01-04
COMPLETEDAnalysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 InfectionNCT04709120 · 2020-10-01
COMPLETEDAnalysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult PatientsNCT04492384 · 2020-06-29
COMPLETEDObservation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease（CKD）Patients With Heart FailureNCT03771729 · 2018-12-30
UNKNOWNRenal Ageing-sarcopenia NetworkNCT04630132 · 2017-03-25
UNKNOWNSerial Biomarker Testing and Cardiovascular Risk Stratification (ACHILLES)NCT07817576 · 2004-01-01
ACTIVE_NOT_RECRUITINGCommon interventions
PlaceboDRUG3Hem-Col Capillary Blood Collection DeviceDIAGNOSTIC_TEST2Withings BPM ConnectDEVICE2Dapagliflozin 10mg TabDRUG1Digital Care Community Common Good ProgramBEHAVIORAL1Empagliflozin 10 MGDRUG1FinerenoneDRUG1genetic polymorphismsGENETIC1Glucose, CreatinineDIAGNOSTIC_TEST1HTD1801DRUG1iABC platform useOTHER1kidney function testDIAGNOSTIC_TEST1LCZ 696DRUG1Living with LTC QuestionnaireDIAGNOSTIC_TEST1MEMS (Medication Electronic Monitoring System) CapDEVICE1Motivational tteachingBEHAVIORAL1non-interventionalOTHER1Observational assessmentOTHER1PeeSpot Urine Collection DeviceDIAGNOSTIC_TEST1placeboOTHER1Placebo 1.5 ml, prefilled pen-injector for subcutaneous injection solutionDRUG1Questionnaire: participants' perspectives toward remote data collectionBEHAVIORAL1Questionnaire: participants' perspectives toward the feasibility of participation in a trial at home with digital technologiesBEHAVIORAL1RetatrutideDRUG1RoxadustatDRUG1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
University Medical Center Groningen
3
Assiut University
2
Eurasian Association of Therapists
2
Barts & The London NHS Trust
1
Chang Gung University of Science and Technology
1
Eli Lilly and Company
1
Geisinger Clinic
1
Hamad Medical Corporation
1
Heart Care Foundation
1
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
1
IRCCS San Raffaele
1
King's College London
1
Kristin Clemens
1
Nova Biomedical
1
Ospedale San Raffaele
1
Trial status mix
COMPLETED9
RECRUITING6
UNKNOWN6
NOT_YET_RECRUITING2
TERMINATED2
ACTIVE_NOT_RECRUITING1
Phase mix
NA4
PHASE24
PHASE43
PHASE32
EARLY_PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.